Morgan Stanley
-
-
-
-
-
-
-
Morgan Stanley Reiterates Overweight Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Notable Analyst Rating Changes 5/24: (SQ) (MSFT) (DE) Upgraded; (TWTR) (CF) (CYH) Downgraded
-
-
219,877 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

